Skip to content

AHC International Media Library

Alternating Hemplegia of Childhood and ATP1A3 disorders

  • Interviews
  • Home Videos
  • News
  • Associations
  • Documentaries
  • Presentations
  • Contact
  • About AHCIM
  • Articles
  • Toggle search form

Alfred George at the ATP1A3 symposium in disease, Chicago 2018

Posted on November 25, 2018 By siggi

Really good interview with Dr. Alfred George who sums up why we are having these symposiums, what has been achieved and where we are headed to find a treatment for ATP1A3 diseases.

Alfred L. George, Jr., MD
Chair, Department of Pharmacology
Director, Center for Pharmacogenomics
Magerstadt Professor of Pharmacology
Professor of Pharmacology

Interviews Tags:Alfred Georg, atp1a3, atp1a3 reykjavik, ATP1A3 Symposium, chicago, nortwestern, parent group, pharmacology, reserach

Post navigation

Previous Post: Fiorella Gurrieri at the ATP1A3 Symposium in Disease, Chicago 2018
Next Post: Arn M.J.M. van den Maagdenberg at the ATP1A3 symposium in disease – Chicago 2018

Related Posts

Elisa de Grandis – London 2016 Interviews
Kenneth Silver – Why do not all AHC Patients have the ATP1A3 mutation? 2/3 Interviews
Tara Newcomb – Minneapolis 2014 Interviews
Dr. Al George – AHC interview 2019 – Reykjavik, Iceland Interviews
Barbara and Tom Cave Interviews
ATP1A3 Symposium in Disease – Reykjavik 2019 Associations

Copyright © 2026 AHC International Media Library.

Powered by PressBook Masonry Dark